 Overactivity of the sympathetic nervous system is thought to contribute to the pathophysiology of congestive heart failure CHF. Blockade of the sympathetic nervous system with β-adrenergic inhibitors could be expected to ameliorate these detrimental effects in a manner analogous to the effects of the angiotensin converting enzyme inhibitors on the overactive renin-angiotensin system. 